期刊
NEUROBIOLOGY OF AGING
卷 33, 期 7, 页码 1203-+出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2010.10.019
关键词
Alzheimer's disease; Dementia; Mild cognitive impairment; Mild cognitive impairment (MCI); Autopsy-confirmation; Biomarkers; Early detection; Cerebrospinal fluid; Cerebrospinal fluid (CSF); A beta(1-42); Tau; p-tau; MRI; Hippocampus; Volumetry; Entorhinal cortex; Prodromal; ADNI
资金
- Science Foundation Ireland (SFI) [08/IN.1/B1846]
- National Institute on Aging [AG19610, AG024904, AG025526, AG11378]
- NIH Foundation
- Evelyn F. McKnight Brain Institute of the University of Arizona
- state of Arizona
- Mayo Clinic
- Pfizer
- Eisai
- Novartis
- Lilly
- AstraZeneca
- Sanofi
- NIH
- CIHR
- Alzheimer Society of Canada
- Michael Smith Health Research Foundation
- NIA [UO1 AG-024904]
- Janssen
- Arizona Department of Health Services
The current study tested the accuracy of primary MRI and cerebrospinal fluid (CSF) biomarker candidates and neuropsychological tests for predicting the conversion from mild cognitive impairment (MCI) to Alzheimer's disease (AD) dementia. In a cross-validation paradigm, predictor models were estimated in the training set of AD (N = 81) and elderly control subjects (N = 101). A combination of CSF t-tau/A beta(1-4) ratio and MRI biomarkers or neuropsychological tests (free recall and trail making test B (TMT-B)) showed the best statistical fit in the AD vs. HC comparison, reaching a classification accuracy of up to 64% when applied to the prediction of MCI conversion (3.3-year observation interval, mean = 2.3 years). However, several single-predictor models showed a predictive accuracy of MCI conversion comparable to that of any multipredictor model. The best single predictors were right entorhinal cortex (prediction accuracy - 68.5% (95% CI (59.5, 77.4))) and TMT-B test (prediction accuracy 64.6% (95% CI (55.5, 73.4%))). In conclusion, short-term conversion to AD is predicted by single marker models to a comparable degree as by multimarker models in amnestic MCI subjects. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据